Medicare costs estimated to top $21.1 billion for 5 years of care for elderly cancer patients

User rating: not rated yet

The cost of cancer care for elderly Medicare patients varies by tumor type, stage at diagnosis, phase of care, and survival, according to a new study published online April 29 in the Journal of the National Cancer Institute. The 5-year cost is highest for patients with lung, colorectal, and prostate cancers. The estimated cost for 5 years of care for elderly Medicare patients diagnosed with cancer in 2004 is $21.1 billion.


Full story »

All News summaries from Medicine & Health news
All News summaries for April 29, 2008

Just a numbers game? Making sense of health statistics

8 hours ago | User rating: not rated yet
Presidential candidates use them to persuade voters, drug companies use them to sell their products, and the media spin them in all kinds of ways, but nobody - candidates, reporters, let alone health consumers - understands ...

Statins may prevent miscarriages

11 hours ago | User rating: not rated yet
Hospital for Special Surgery researchers have found that statins may be able to prevent miscarriages in women who are suffering from pregnancy complications caused by antiphospholipid syndrome (APS), according to a study ...

A link between mitochondria and tumor formation in stem cells

12 hours ago | User rating: not rated yet
Researchers report on a previously unknown relationship between stem cell potency and the metabolic rate of their mitochondria –a cell's energy makers. Stem cells with more active mitochondria also have a greater capacity ...

Researcher eliminates viral vector in stem cell reprogramming

12 hours ago | User rating: not rated yet
Shinya Yamanaka MD, PhD, of Kyoto University and the Gladstone Institute of Cardiovascular Disease (GICD) has taken another step forward in improving the possibilities for the practical application of induced pluripotent ...

On the trail of a targeted therapy for blood cancers

Oct 10, 2008 | User rating: not rated yet
Investigators from the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine are focusing on a family of blood proteins that they hope holds a key to decreasing the toxic ...